Ignite Creation Date:
2025-12-24 @ 12:05 PM
Ignite Modification Date:
2025-12-26 @ 9:37 PM
Study NCT ID:
NCT04234061
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-11-07
First Post:
2020-01-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma
Sponsor:
Peter MacCallum Cancer Centre, Australia
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-07
Start Date Type:
ACTUAL
Primary Completion Date:
2027-09-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-05
First Submit QC Date:
None
Study First Post Date:
2020-01-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-06
Last Update Post Date:
2024-11-07
Last Update Post Date Type:
ACTUAL